In understanding what makes the patient voice so essential to successful drug development, let’s take a critical eye to what ...

The FDA has said it needs more information before it can approve Regenxbio's gene therapy for Hunter syndrome, driving the ...

The acceptance of the new drug application (NDA) puts oveporexton in pole position to become the first orexin agonist to be ...

AstraZeneca has reported a strong set of fourth-quarter results and predicted a similarly strong performance for 2026, as it ...

The conversation also explores the role digital health technologies like RFID and predictive analytics could play in ...

In a statement, Japan's Astellas said the specific terms of the settlement were confidential; however, a regulatory filing ...

Hengrui Pharma and partner Kailera have joined the ranks of companies with clinical data in hand for an oral drug for weight loss, reporting weight loss of up to 12.1% in a phase 2 trial with their ...

Takeda has joined forces with Iambic Therapeutics on a multiyear collaboration to use the US biotech's AI-driven, structure-based drug discovery platform to find new therapies for gastrointestinal and ...

A universal vaccine would work to help combat the development of AMR in several ways. Firstly, it would protect the individual from getting infected. Prevention of primary infection removes the ...

Roche has revealed the data behind a positive phase 3 trial for its oral BTK inhibitor fenebrutinib in primary progressive ...

The 466,000 sq ft centre will serve as a hub to join Novartis' current R&D sites in Cambridge, Massachusetts, and Basel, ...

Eli Lilly has signed its second pipeline-building deal in two days, reaching an agreement to buy in vivo CAR-T developer Orna ...